Levantamento diagnóstico para otimização da nanoregulação nacional de produtos para saúde

Abstract

Nanotechnology refers to the application of scientific knowledge in the control of matter at the nanoscale, in the range between 1nm and 100nm. Recent studies point to the risks that this new technology can cause to human life and to the environment, due to the insufficient knowledge of its properties and effects, being necessary the regulation of these products, their ethical implications and vigilant organs that accompany the discoveries Technological developments. Thus, this study aimed to perform an updated diagnosis based on national and international technical standards that govern the application of nanotechnology in health products through an integrative review. A total of 524 articles were found in three databases, LILACS, Scielo and PubMed, of which 61 articles were read from the final set. The methodology consisted of five steps: definition of the guiding question, search of studies in different databases, selection of studies, critical evaluation of studies and synthesis of data. The results obtained in the integrative review show that nations such as Japan, USA and of EU have demonstrated the highest level of development in nanotechnology, being representative in this study in order to compare with the advances of nanoscience in Brazil, therefore that there is no unanimous global regulation for nanotechnology worldwide, given the lack of scientific evidence regarding the risk to human health and the environment, suggesting that the regulation adopted should be based on the precautionary principle and be assessed on a case by case basis. This work served as a synthesis in the diagnosis of the needs for the construction of a regulation that is followed worldwide.